+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Albert Baikie Memorial Medal & Award

Haematology Society of Australia & New Zealand

The Albert Baikie Award is given to recognise the best presentation, either oral or poster, at the Annual Scientific Meeting by a new investigator who is a financial member of the Haematology Society of Australia and New Zealand. The winner receives a $5,000 prize and is presented with the Albert Baikie Memorial Medal.

This prestigious award is open to new investigators who were awarded their postgraduate qualification (MSc, FRACP, FRCPA or PhD) within the past 5 years.

Special consideration may be made by Council for those people who wish to apply but who, for other reasons, completed their postgraduate qualification more than 5 years ago.

Conditions

Applicants must be financial and either full, trainee or associate members of HSANZ by the time of the Annual Scientific Meeting. You can apply for membership to HSANZ at www.hsanz.org.au. Application for the award is via on-line abstract submission at the meeting website Blood2025

Only ONE abstract is to be nominated by each applicant

Previous winners of the award are ineligible

All applications will be assessed by a subcommittee of the HSANZ and will be judged on the quality and originality of the work and presentation.

The closing date for applications is the same as for abstraction submission and the award is announced on the last day of the annual scientific meeting, Blood 2025

Recipients of travel grants are eligible for the Albert Baikie Award but a separate application must be completed for each.

Applications are now open for this award and will close when abstract submission closes on 1 May 2025.

AI Based Application Success Predictor

Based on HSANZ programs and funding patterns:

🥇 1. Strong Hematology Relevance (Top Predictor)

Must address:
- Leukemia, lymphoma
- Anemia
- Coagulation disorders
- Transfusion medicine

✔ Direct relevance to blood diseases is essential

🥈 2. Clinical / Translational Impact

Preference for:
- Patient-oriented research
- Studies improving diagnosis or treatment

✔ High success:

Clinical trials
Outcome studies

🥉 3. Early Career Investigator Focus

Many HSANZ grants target:
- Trainees
- Fellows

✔ Predictor:

Strong mentorship and institutional support

4. Feasibility & Practical Scope

Typically:
- Small to moderate grants

✔ Winning proposals:

Realistic timelines
Achievable objectives

5. Use of Clinical Data / Cohorts

Preferred:
- Patient registries
- Clinical datasets

✔ Strengthens translational value

6. Collaboration Across Institutions

Multi-center or regional collaboration:
- Increases competitiveness

7. Innovation in Hematology

Competitive areas:
- Precision medicine
- Targeted therapies
- Biomarkers

8. Clear Study Design & Outcomes

Must include:
- Defined endpoints
- Robust methodology

🧪 Common Funded Research Areas

Hematologic malignancies (leukemia, lymphoma)
Bone marrow transplantation
Coagulation and thrombosis
Transfusion medicine
Precision medicine in hematology

⚠️ Common Reasons for Rejection

Weak hematology focus
Lack of clinical relevance
Poor study design
Overly ambitious proposals
No measurable outcomes

🧠 Bottom Line (Key Predictors Ranked)

Direct relevance to hematology
Clinical/translational impact
Early-career focus + mentorship
Feasible, well-designed study
Use of clinical data
Collaborative approach

Specialties

Hematology

Eligibility Requirements

Recipients of travel grants are eligible for the Albert Baikie Award but a separate application must be completed for each.

Previous winners of the award are ineligible

Eligible Countries:

Australia

New Zealand

Sponsor Details

Sponsor Institute/Organizations: Haematology Society of Australia & New Zealand

Sponsor Type: Corporate/Non-Profit

Address: 145 Macquarie Street, Sydney NSW 2000 hsanz@hsanz.org.au

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity